Ad is loading...
MFVFX
Price
$16.28
Change
-$0.09 (-0.55%)
Updated
Nov 15 closing price
RWMEX
Price
$63.76
Change
-$0.73 (-1.13%)
Updated
Nov 15 closing price
Ad is loading...

MFVFX vs RWMEX

Header iconMFVFX vs RWMEX Comparison
Open Charts MFVFX vs RWMEXBanner chart's image
MassMutual Equity Opports R4
Price$16.28
Change-$0.09 (-0.55%)
VolumeN/A
CapitalizationN/A
American Funds Washington Mutual R4
Price$63.76
Change-$0.73 (-1.13%)
VolumeN/A
CapitalizationN/A
MFVFX vs RWMEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MFVFX vs. RWMEX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MFVFX is a Buy and RWMEX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RWMEX has more cash in the bank: 191B vs. MFVFX (613M). RWMEX pays higher dividends than MFVFX: RWMEX (1.45) vs MFVFX (1.08). MFVFX was incepted earlier than RWMEX: MFVFX (11 years) vs RWMEX (23 years). RWMEX is a more actively managed with annual turnover of: 30.00 vs. MFVFX (24.00). MFVFX has a lower initial minimum investment than RWMEX: MFVFX (0) vs RWMEX (250). RWMEX annual gain was more profitable for investors over the last year : 18.03 vs. MFVFX (14.29). RWMEX return over 5 years is better than : 37.76 vs. MFVFX (1.90).
MFVFXRWMEXMFVFX / RWMEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years23 years-
Gain YTD12.66413.37795%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets613M191B0%
Annual Yield % from dividends1.081.4574%
Returns for 1 year14.2918.0379%
Returns for 3 years-11.7710.11-116%
Returns for 5 years1.9037.765%
Returns for 10 years-23.2956.39-41%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LWAY23.561.17
+5.23%
Lifeway Foods
NOAH11.720.31
+2.72%
Noah Holdings Limited
PEG88.991.99
+2.29%
Public Service Enterprise Group
ANTX1.00N/A
N/A
AN2 Therapeutics
DNB12.12-0.18
-1.46%
Dun & Bradstreet Holdings